Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pusan
Clinical trial register · South Korea

Clinical Trials in Pusan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 2821 Daegu 554 Seongnam-si 493 Busan 468 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
GlaxoSmithKline5 Merck Sharp & Dohme LLC5 ViiV Healthcare3 Seung-Jung Park3 Duk-Woo Park, MD2
Site location
Seoul2821 Daegu554 Seongnam-si493 Busan468 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Pusan

41 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Busan, Daegu, Daejeon, Gwangju, Gyeongsan-si, Pusan, Seoul, Wŏnju
2026-03-26
Not yet open
Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment
NCT07398001Percutaneous Coronary Intervention, Antiplatelet Therapy, Drug-coated Balloon
Ulsan University Hospital
Not applicable
1,042
Ansan, Chuncheon, Pusan, Seoul, Ulsan
2026-02-12
Recruiting
ViiV Healthcare
Phase 2
186
Daegu, Gwangju, Pusan, Seoul
2026-02-11
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Daegu, Seongnam-si, Suwon, Cheongju-si, Goyang-si, Pusan, Yangsan, Jinju
2025-12-22
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Daejeon, Daegu, Busan-si, Pusan, Ulsan, Namdong, Hwasun, Seoul
2025-09-26
Recruiting
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT07002164Myocardial Infarction (MI), Heart Failure
Chonnam National University Hospital
Not applicable
780
Changwon, Daegu, Daejeon, Gwangju, Jeonju, Jinju, Pusan, Seongnam
2025-07-15
Recruiting
Yonsei University
Phase 2
40
Daegu, Daejeon, Hwasun, Jeju City, Pusan, Seoul
2024-12-11
Recruiting
PepGen Inc
Phase 2
24
Pusan, Daegu, Seoul
2024-12-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Wŏnju, Gwangju, Ansan-si, Jinju, Pusan, Deagu, Seoul
2024-12-02
Active, closed
GlaxoSmithKline
Phase 2
283
Ansan, Busan, Pusan, Seoul
2024-11-11
Recruiting
Duk-Woo Park, MD
Not applicable
1,500
Bucheon-si, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon, Pusan
2024-06-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Goyang-si, Seongnam, Suwon, Pusan, Cheongju-si, Busan, Daegu, Junggu
2024-06-11
Recruiting
Eli Lilly and Company
Phase 3
510
Busan, Gyeonggi-do, Pusan, Seongnam-si, Seoul, Suwon
2024-04-29
Recruiting
GlaxoSmithKline
Phase 3
864
Busan, Pusan, Seoul, Suwon Gyeonggi-do
2024-03-21
Recruiting
Neuracle Science Co., LTD.
Phase 1/2
138
Bucheon-si, Gwangju, Ilsan, Pusan, Pyeongchon, Seongnam, Seoul, Suwon
2024-01-19
Recruiting
Double Unit Cord Blood Transplant in Hematologic Malignancies.
NCT06712108Adult Double Unit Cord Blood Transplant
Seoul National University Hospital
Observational
40
Jeonju, Daegu, Pusan, Seongnam, Seoul
2023-12-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Goyang-si, Seongnam, Buk-gu, Pusan, Seoul
2023-12-18
Active, closed
Bristol-Myers Squibb
Phase 2
227
Pusan, Daejeon, Gwangju, Seongnam, Junggu, Seoul, Daegu
2023-11-07
Recruiting
National Cancer Center, Korea
Phase 3
520
Sejong, Goyang-si, Suwon, Pusan, Seoul
2023-05-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Pusan, Seoul
2023-05-31
Recruiting
Fore Biotherapeutics
Phase 2
254
Suwon, Pusan, Hwasun, Seoul
2023-02-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Hwasun, Pusan, Daejeon, Seoul
2023-02-06
Recruiting
Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
NCT05490433Breast Cancer Classified as TNM Stage 0-IIIa
Yonsei University
Not applicable
790
Changwon, Daegu, Goyang-si, Incheon, Pusan, Sejong, Seoul, Yongin-si
2022-10-26
Active, closed
GC Biopharma Corp
Phase 1
12
Pusan, Seoul
2022-09-20
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Pusan, Junggu, Seoul
2022-08-23
Active, closed
Hanmi Pharmaceutical Company Limited
Phase 2
17
Pusan, Seoul
2022-05-05
Active, closed
GlaxoSmithKline
Phase 2
360
Ansan-si Gyenggi-do, Busan, Pusan, Seoul
2021-12-14
Active, closed
GlaxoSmithKline
Phase 2/3
758
Cheongju Chungcheongbuk-do, Daegu, Gyeonggi-do, Pusan, Seongnam-si Gyeonggi-do, Seoul, Suwon Kyunggi-do
2020-12-08
Recruiting
Duk-Woo Park, MD
Observational
2,000
Chuncheon, Daegu, Daejeon, Gangneung, Kwangju, Pusan, Seoul, Suncheon
2020-09-17
Active, closed
GlaxoSmithKline
Phase 3
494
Pusan, Ulsan
2020-05-07
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
95
Gyeonggi-do, Seongnam-si, Suwon, Pusan, Hwasun, Incheon, Cheongju-si, Busan
2020-01-07
Recruiting
Pusan National University Yangsan Hospital
Not applicable
30
Pusan
2020-01-01
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Seoul, Daegu, Pusan, Seongnam
2019-03-11
Recruiting
Seung-Jung Park
Observational
500
Bucheon-si, Daegu, Daejeon, Gwangju, Pusan, Seongnam, Seoul
2018-09-04
Active, closed
Seung-Jung Park
Not applicable
2,008
Daegu, Daejeon, Gwangju, Pusan, Seoul
2018-04-12
Active, closed
ViiV Healthcare
Phase 3
1,049
Daegu, Daejeon, Pusan, Seoul
2017-10-27
Active, closed
Samsung Medical Center
Not applicable
240
Goyang-si, Pusan, Seongnam, Seoul
2017-10-20
Active, closed
ViiV Healthcare
Phase 3
618
Daegu, Daejeon, Pusan, Seoul
2016-10-28
Recruiting
Young-Hak Kim, MD, PhD
Not applicable
1,000
Seoul, Anyang, Chuncheon, Daegu, Pusan
2014-08-12
Recruiting
Drug-Eluting Balloon Registry in Routine Clinical Practice
NCT02038660Coronary Artery Disease, Angioplasty, Balloon
Seung-Jung Park
Observational
1,500
Bucheon-si, Daegu, Daejeon, Gwangju, Pusan, Seoul, Ulsan
2014-01
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Daegu, Gwangju, Pusan, Seongnam, Seoul
2013-10-14
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/pusan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies with a site in Pusan.

How many clinical trials are recruiting in Pusan?

24 of the 41 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pusan), 41 studies
PhaseStudiesRecruitingShare
Phase 314734.1%
Phase 29522%
Not applicable8519.5%
Observational449.8%
Phase 1/2327.3%
Phase 2/3214.9%
Phase 1102.4%

Most active sponsors

Lead sponsors with the most studies (Pusan)
Lead sponsorStudiesRecruiting
GlaxoSmithKline51
Merck Sharp & Dohme LLC53
Seung-Jung Park32
ViiV Healthcare31
Duk-Woo Park, MD22
Eli Lilly and Company22
Yonsei University22
Aptose Biosciences Inc.11
Aragon Pharmaceuticals, Inc.10
Bristol-Myers Squibb10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.